The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II trial of pazopanib alternating with bevacizumab in treatment-naïve metastatic clear cell renal cell carcinoma (CCRCC) patients: Phase I results.
 
Saby George
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Corvus Pharmaceuticals; Exelixis; Genentech/Roche; Janssen Oncology; Novartis; Pfizer; Sanofi
Research Funding - Acceleron Pharma (Inst); Agensys (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Laurie Herbst
No Relationships to Disclose
 
Marcus Sikorski
No Relationships to Disclose
 
Ann Marie Diraddo
No Relationships to Disclose
 
Gissou Azabdaftari
No Relationships to Disclose
 
Charles Roche
No Relationships to Disclose
 
Eric Kauffman
No Relationships to Disclose
 
Qiang Li
No Relationships to Disclose
 
Thomas Schwaab
No Relationships to Disclose
 
Ellis Glenn Levine
Patents, Royalties, Other Intellectual Property - UpToDate
 
Roberto Pili
Consulting or Advisory Role - Exelixis; Ipsen; Prometheus
Research Funding - Active Biotech; ARIAD; Millennium; Peregrine Pharmaceuticals; Pfizer; Syndax
 
Gurkamal S. Chatta
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Leonard Joseph Appleman
Research Funding - Acerta Pharma (Inst); Agensys (Inst); Astellas Pharma (Inst); AVEO (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Inovio Pharmaceuticals (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Tokai Pharmaceuticals (Inst)
 
Adrienne Groman
No Relationships to Disclose
 
Rahul Atul Parikh
Stock and Other Ownership Interests - Immunomedics (I)
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Seattle Genetics/Astellas
Research Funding - Saladax Biomedical; Taiho Pharmaceutical
Patents, Royalties, Other Intellectual Property - Patents on DNA repair pathways in cancer. I do not receive any royalties for the same.
Travel, Accommodations, Expenses - AstraZeneca; Seagen
 
Alan Hutson
No Relationships to Disclose